Matthew Davidson, Ph.D.
Equibles does not estimate personal net worth.
Get an email with a short summary when Azora Therapeutics, Inc. (DE) publishes a filing, an earnings call transcript or a press release.
Get AZR alertsAbout Matthew Davidson, Ph.D.
Matthew Davidson, Ph.D. is recorded as CEO at Azora Therapeutics, Inc. (DE) (AZR) since October 28, 2026. Azora Therapeutics, Inc. (DE) reported in an 8-K filed October 28, 2026 that Matthew Davidson, Ph.D. was appointed President and Chief Executive Officer, effective October 28, 2026. Azora Therapeutics, Inc. (DE) is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Azora Therapeutics, Inc. (DE) includes Matthew Davidson (CEO), William B. Stilley (CEO), Kevin Schuyler (Chairman) and 7 others.
“The Board of Directors (the “***Board***”) of Azora Therapeutics, Inc., formerly known as Adial Pharmaceuticals, Inc. (the “***Company***”), appointed Matthew Davidson, Ph.D. as President and Chief Executive Officer of the Company, on October 28, 2026 (the “***Effective Date***”).”
Affiliation history
-
Current
2026-10-28–present
Company network
Leadership on record at Azora Therapeutics, Inc. (DE)
- Matthew Davidson CEO
- William B. Stilley CEO
- Kevin Schuyler Chairman
- Celia Economides CFO
- Vinay K. Shah CFO
- Cary Claiborne COO, Board Member
- Cary J. Claiborne COO, Board Member
- Tony Goodman COO
- Dr. Jack Reich Board Member
- Matt Davidson Board Member